GLP-1 medication tracker
FDA filedCagriSema tracker
CagriSema, tracked privately: the weekly cagrilintide + semaglutide shot.
CagriSema is a once-weekly injectable that combines cagrilintide (an amylin analog) with semaglutide (a GLP-1) in a single pen, under FDA review for weight management. Whether you're in a trial or tracking it yourself, Lirea keeps a private, accurate record, kept on your phone, with no account.
One email on launch day, and nothing else. The app itself never asks for one.
Today
Your shot dayThis week
CagriSema
Logged
Weight check-in
What you'll track
Made for how you actually take CagriSema.
A once-weekly single-pen injection (cagrilintide + semaglutide).
One pen, tracked simply
CagriSema delivers two medications in one weekly shot. Lirea logs it as a single dose and reminds you before it's due.
Follow your dose as it steps up
Both components climb to their maintenance dose over time. Lirea shows which step and week you're on, with holds and step-backs.
Weight as the outcome that matters
Watch your weight as a trend across months, and how it moves as your dose climbs.
Side effects, in context
Log nausea or appetite changes against your dose timing so the pattern is visible, not guesswork.
Why Lirea
Your CagriSema data is nobody's business but yours.
No employer, insurer, or wellness platform ever sees what you log, and neither do we. It's stored and encrypted on your device, with no account and no server in the middle.
How your data stays yoursNo account
Open the app and start. We never ask who you are.
On-device
Your data is stored and encrypted on your phone.
No analytics SDKs
No Firebase, no trackers, no ad networks.
Check it yourself
Turn on airplane mode. Everything but the paywall still works, because there is nothing on the other end.
Questions
CagriSema, tracked privately
Is CagriSema approved?
Not yet. As of 2026 CagriSema is under FDA review (filed late 2025) and is not yet approved. Lirea tracks whatever your provider or trial has you on; it doesn't sell or supply any medication.
What's the difference between CagriSema and a regular GLP-1?
CagriSema pairs a GLP-1 (semaglutide) with an amylin analog (cagrilintide) for an added appetite mechanism, in one weekly pen. Lirea tracks it like any weekly shot.
Is my CagriSema data private?
Yes. Everything is stored and encrypted on your device, with no account and no server.
Related trackers
Lirea is a private tracking tool, not a medical device, a pharmacy, or a source of medical advice. Anything shown here is general reference, not a recommendation. Always follow the guidance of a qualified healthcare provider.
Launching soon
Keep it, and keep it yours.
Track your weekly dose, your titration, and how you’re feeling, all on your device. No account required. Be first to know when Lirea is live.